Hirva Mamdani, MD, assistant professor of medicine, Department of Oncology, Barbara Ann Karmanos Cancer Institute, discusses the need to develop novel therapies in locally advanced esophageal and gastroesophageal junction (GEJ) adenocarcinoma
Dr. Mamdani on the Need for Novel Therapies in Locally Advanced Esophageal/GEJ Adenocarcinoma